Regulatory Situation of Herbal Medicines - A Worldwide Review
(1998; 49 pages) [French] [Spanish] Ver el documento en el formato PDF
Índice de contenido
Ver el documentoACKNOWLEDGEMENTS
Ver el documentoFOREWORD
Abrir esta carpeta y ver su contenidoI. INTRODUCTION
Cerrar esta carpetaII. REGULATORY SITUATION
Abrir esta carpeta y ver su contenidoAfrica
Abrir esta carpeta y ver su contenidoThe Americas
Abrir esta carpeta y ver su contenidoEastern Mediterranean
Cerrar esta carpetaEurope
Ver el documentoGeneral aspects
Ver el documentoAttempts to Meet the Need for Harmonization
Ver el documentoAustria
Ver el documentoBelgium
Ver el documentoBulgaria
Ver el documentoDenmark
Ver el documentoEstonia
Ver el documentoFinland
Ver el documentoFrance
Ver el documentoGermany
Ver el documentoGreece
Ver el documentoHungary
Ver el documentoIceland
Ver el documentoIreland
Ver el documentoItaly
Ver el documentoNetherlands
Ver el documentoNorway
Ver el documentoPortugal
Ver el documentoSpain
Ver el documentoSweden
Ver el documentoSwitzerland
Ver el documentoTurkey
Ver el documentoUnited Kingdom
Abrir esta carpeta y ver su contenidoSouth East Asia
Abrir esta carpeta y ver su contenidoWestern Pacific
Ver el documentoIII. CONCLUSION
Ver el documentoIV. REFERENCES
 

Italy

On 8 January 1981, a guideline was issued by the Italian Health Authority classifying herbal products as medicines or health food products respectively [83].

The first type of herbal product covers plants traditionally used as food or flavour. They serve for nutritional purposes and are not allowed to claim therapeutic indications. They are classified as dietetic products and do not need an approval, but the authority has to be notified of the label. These products are allowed to be sold outside pharmacies, in so-called "erboristerias" which are also regulated in this guideline. The responsible person for the "erboristeria", the "erborista", is not allowed to give recommendations on the use of herbal products. The "erborista" can sell herbal products which are not pharmacy-bound, but is not allowed to prepare mixtures of these products.

Herbal products that make therapeutic claims, that have a particular pharmacological activity or that might be toxic, are considered as medicines and are only allowed to be sold through pharmacies. Mixtures of herbs, such as herbal teas or similar preparations, with a brand name and/or therapeutic indications have to be registered as medicinal products. They are only allowed to be sold by a pharmacist in a pharmacy. The "erborista" is not allowed to sell medicinal plants for therapeutic purposes, whereas the pharmacist is allowed to prepare and to sell mixtures of medicinal plants to the public.

The guideline contains two annex lists, one for medicinal plants which may only be sold in pharmacies, and a second list of plants that may be sold outside pharmacies.

When registered as a medicine, a herbal product needs a leaflet which gives information on indication claims, risk, dosage, etc. According to this guideline, the application dossier must contain a technical-analytical documentation. With respect to the pharmacological, toxicological, and clinical documentation, a bibliographic application in accordance with the Directive 65/65/EEC is possible [83].

Ir a la sección anterior Ir a la siguiente sección
 

Última actualización: le 3 mayo 2013